ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

N4P N4 Pharma Plc

0.525
0.075 (16.67%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.075 16.67% 0.525 0.50 0.55 0.525 0.45 0.45 4,522,734 16:04:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 2k -1.27M -0.0047 -1.11 1.21M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.45p. Over the last year, N4 Pharma shares have traded in a share price range of 0.412p to 1.80p.

N4 Pharma currently has 268,780,349 shares in issue. The market capitalisation of N4 Pharma is £1.21 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.11.

N4 Pharma Share Discussion Threads

Showing 8401 to 8422 of 8625 messages
Chat Pages: 345  344  343  342  341  340  339  338  337  336  335  334  Older
DateSubjectAuthorDiscuss
16/1/2024
08:00
Preclinical studies!! Need I say more….
nobbygnome
11/1/2024
11:33
To add to my previous posting, a couple of further observations regarding Nanogenics/Nuvec. Firstly people say that N4 only has one product and that it is years away from monitisation. This is only partially true because the investment in Nanogenics gives them both a product that is near to clinic,which even in its non refined state is better than anything on the market that addresses a clear and growing need, together with a string of other promising products. To quote from the Nanogenics website "Our lead product, ECP-105, is our novel glaucoma therapy. We expect to have it in clinic in 2025, followed closely by several other promising medicines." The Nanogenics investment therefore gives them plenty of options.
The other comment I would make is that Nuvec being a delivery system means that it has in the past been beholden to the drug developers to get Nuvec into clinic. The company have spoken before about bringing their own products to market and what the Nanogenics investment does is bring a drug developer together with a delivery system meaning that N4 are no longer beholden to third party drug developer timescales, indeed N4 have already stated that the next stage of Nuvecs development is to identify a clear product to take into clinic.
Nuvec could be used for Nanogenics drug development or Nanogenics could develop drugs for Nuvec. Either way it speeds up the timelines to get into clinic.

fydo
08/1/2024
15:12
Hmmmm Fydo’s first post since October 2019 and as far as I can see he has never posted on N4P before. Who has tipped him the wink….
nobbygnome
08/1/2024
11:26
Things are coming together here and the dots are being joined. One of the issues being discussed is funding. N4 have already stated that Nanogenics could be funded by third parties. To this end it is interesting that Dr Simon Newman the Chief Scientific officer of Nanogenics will take up the same role at the Brain Tumour Charity next month whilst continuing that role at Nanogenics. Interesting because the Brain Tumour Charity is both heavily involved in tumour research itself but more importantly is a major financier of tumour research both directly and through third parties. To have the Nanogenics CSO acting in the interests of Nanogenics/Nuvec could be very advantageous.
fydo
08/1/2024
07:35
Insider trading?!? Hmmmm…

I thought it was funny that they referenced immunogenicity problems with the viral vector. They haven’t put the Nuvec particles into humans yet so have no idea if there will be any tolerability issues with their own product!

This project remains many years from monetisation….

nobbygnome
08/1/2024
07:29
Explains the £55k late reported buy on Friday with the RNS this morning.
mo7800
07/1/2024
15:08
Well hope they continue to go up tomorrow.
pwal
07/1/2024
14:38
They had a few other ideas, re-engineering Viagra etc that failed, now a slow slog to prove what they are left with (nuvec) works.
tp6
05/1/2024
11:14
Because they've got 1 early stage product, no revenue and no money
dplewis1
05/1/2024
10:04
I bought into this as a punt at 0.77p. I have done some research into this and it's got an awful lot of upside to it. Why did it drop from 12p all the way down?
mo7800
19/12/2023
08:17
Yeah but it's 20 years now they have been flogging that horse or land in Greece so you cannot say one stock is lifestyle and another is not when most are when it comes to this game.

And yes the future is not the past

dave4545
19/12/2023
08:14
No it isn’t as the directors have largely been paying themselves in shares. The issues there are caused by the delightful Foundation…230; and the spike you talk about should be early next year, although I doubt it will come down again.
nobbygnome
18/12/2023
22:21
So Minoan is not a lifestyle stock then Nobby ? :-))

They're all lifestyle stocks, the key is to be in them at the right time before they spike a few times a year.

dave4545
18/12/2023
21:43
As a long term investor here after a fall from 5p to 0.7 in 2 years, you then celebrate a rise to 1.1. It’s still down the best part of 80%. Hmmmm….
nobbygnome
18/12/2023
21:20
A long downtrend with a 40% burst. Good one.
featherby81
18/12/2023
21:16
The chart above looks like one long downtrend to me….
nobbygnome
18/12/2023
20:58
You still trolling chat boards you ain’t invested in and missing out on gains I see Nobby! #Winner
featherby81
18/12/2023
20:31
Another nothing announcement; this technology is sooooooooo far from being commercialised. A triumph of hope over expectation….
nobbygnome
18/12/2023
17:59
Profit taken & money moving to APH
blackhorse23
18/12/2023
14:45
I agree Dave. News has not been reflected in the current rise yet but it feels like its about to pop into close. Enjoy the week.
genierub
18/12/2023
12:17
Definitely looking better though -

If seller has departed this is 1p+ -

tomboyb
18/12/2023
12:13
My break even is 4p. Not sure it will get to that anytime soon. But hope is there.
pwal
Chat Pages: 345  344  343  342  341  340  339  338  337  336  335  334  Older

Your Recent History

Delayed Upgrade Clock